Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study

AIM: Cardiovascular disease is a leading cause of mortality among long-term cancer survivors treated with large total doses of doxorubicin. An increase in coronary artery disease (CAD) among childhood cancer survivors by age 45 has been observed and is driven by primarily anthracycline chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Laurence H., Boonstra, Philip S., Reinke, Denise K., Antalis, Erin J. Peregrine, Zebrack, Bradley J., Weinberg, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513741/
https://www.ncbi.nlm.nih.gov/pubmed/34651082
http://dx.doi.org/10.20517/2394-4722.2020.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513741/
https://www.ncbi.nlm.nih.gov/pubmed/34651082
http://dx.doi.org/10.20517/2394-4722.2020.36

Ejemplares similares